UK healthcare informatics provider, Epro, has appointed Kat Hancock as business development director in a new position for the organisation that reflects its growth ambitions and NHS demand for its clinical software applications.
With over eight years experience in healthtech business development roles for organisations including IntelliCentrics, DrDoctor, and Okadoc, plus an extensive background working in the NHS as a mental health support worker, Hancock brings an innate understanding of today’s healthcare challenges, which combined with her problem-solving attitude, will add further breadth and depth to Epro’s experienced leadership team.
Within her role at Epro, she will oversee the development of new business development strategies and opportunities, as well as champion brand awareness and marketing initiatives to drive the growth of new client relationships with the aim of further expanding the presence of Epro’s modular clinical platform within trusts as a viable, user-friendly, and cost-effective alternative to large-scale EPR implementations.
She said: “I’m delighted to be joining Epro at such an exciting time.
“Our aim is to support NHS users through the benefits of increased availability of clinical information, in a rapidly-accessible format, which is captured efficiently and at minimal possible cost to the organisation.
“As an ex-NHS employee, I appreciate first-hand the frustrations that can be associated with trying to navigate different software solutions without sufficient training and support. So, to join a team that is dedicated to supporting clinicians and making their clinical workflows easier is just fantastic.”
Jonathan Elliott, managing director, adds: “Epro’s success is proven by the longevity of our existing client relationships, but there are many more trusts out there who could really benefit from our solution.
“We believe Kat’s first-hand experience of, and passion for, the NHS, particularly within the mental health field, will allow her to drive this growth to the overall benefit of clinicians, patients, and the broader healthcare ecosystem.”